Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	193.71	128.39	97.25	186.73	125.74	123.67
Short-Term Investments	354.07	438.97	321.66	154.89	111.61	203.24
Cash & Short-Term Investments	547.79	567.36	418.91	341.62	237.36	326.9
Cash Growth	-4.63%	35.44%	22.63%	43.93%	-27.39%	6.90%
Other Receivables	53.66	0.12	165	10	0.01	4.36
Total Trade Receivables	53.66	0.12	165	10	0.01	4.36
Other Current Assets	12.01	10.09	7.73	3.96	5.71	9.48
Total Current Assets	613.46	577.57	591.64	355.58	243.08	340.74
Net Property, Plant & Equipment	11.17	11.69	12.61	2.15	4.63	6.73
Long-Term Investments	72.55	78.64	140.25	-	-	-
Other Long-Term Assets	0.29	0.29	0.23	0.23	0.23	0.23
Total Assets	697.46	668.19	744.73	357.95	247.93	347.7
Accounts Payable	8.44	5.34	1.62	0.78	3.71	2.5
Accrued Expenses	17.49	28.27	23.69	19.36	24.96	37.72
Current Portion of Leases	2.34	2.28	0.51	1.14	2.52	2.2
Unearned Revenue	6.28	9.55	18.89	-	-	1.6
Other Current Liabilities	-	-	2.69	-	-	-
Total Current Liabilities	34.55	45.44	47.4	21.27	31.18	44.02
Long-Term Leases	7.44	8.04	10.36	-	1.14	3.66
Other Long-Term Liabilities	-	-	11.68	-	-	-
Total Long-Term Liabilities	7.44	8.04	22.03	-	1.14	3.66
Total Liabilities	41.99	53.48	69.43	21.27	32.32	47.67
Common Stock	0	0	0	0	0	-
Additional Paid-in Capital	1,123	1,085	1,016	952.49	752.72	709.68
Accumulated Other Comprehensive Income	-0.27	0.64	-0.08	-0.11	-0.36	-0.3
Retained Earnings	-	-470.67	-340.52	-615.71	-536.76	-409.36
Shareholders' Equity	1,122	614.71	675.3	336.68	215.61	300.02
Total Liabilities & Equity	697.46	668.19	744.73	357.95	247.93	347.7
Total Debt	9.78	10.32	10.87	1.14	3.66	5.86
Net Cash (Debt)	538.01	557.04	408.05	340.48	233.7	321.04
Net Cash Growth	-3.42%	36.51%	19.85%	45.69%	-27.21%	7.07%
Net Cash Per Share	8.22	8.76	6.27	6.00	4.76	6.93
Book Value	1,122	614.71	675.3	336.68	215.61	300.02
Book Value Per Share	17.15	9.67	10.38	5.93	4.40	6.48
Tangible Book Value	1,122	614.71	675.3	336.68	215.61	300.02
Tangible Book Value Per Share	17.15	9.67	10.38	5.93	4.40	6.48

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q